Table 3 Anemia and its associated factor before HAART initiation in HIV patients attending University of Gondar hospital, North West Ethiopia from 2008-2013
Variables | Anemic | Non-anemic | X2 | P value | |
|---|---|---|---|---|---|
Sex | Male | 26 (19.8%) | 105 (80.2%) | 0.23 | 0.63 |
Female | 48 (22%) | 170 (78%) | |||
Age | <25 years | 14(30.4%) | 32(69.6%) | 3.44 | 0.33 |
26-35 years | 32(20.8%) | 122(79.2%) | |||
36-45 years | 23(20.2%) | 91(79.8%) | |||
>46 years | 5(14.3%) | 30(85.7%) | |||
Opportunistic infection | Yes | 8(53.3%) | 7(46.7%) | 9.68 | 0.002 |
No | 66(19.8%) | 268(80.2%) | |||
WHO stage | WHO stage I & II | 42(30.1%) | 184(169.7%) | 2.61 | 0.455 |
WHO stage III & IV | 32(53.7%) | 91(145.7%) | |||
CD4 cells//μl | <200 | 50(35.2%) | 92(64.8%) | 31.25 | 0.000 |
200-350 | 20(15.5%) | 109(84.5%) | |||
>350 | 4(5.1%) | 74(94.9%) | |||